GEHC

4 - GE HealthCare Technologies Inc. (0001932393) (Issuer)

8-K - GE HealthCare Technologies Inc. (0001932393) (Filer)

GE HealthCare (NASDAQ:GEHC), a leading global precision care innovator, today announced the appointment of William (Bill) Grogan as Chief Financial Officer, effective September 14, 2026. Grogan succeeds Jay Saccaro, who, as previously announced, stepped down for an expanded role outside of the medical technology industry. George Newcomb, who is serving as interim Chief Financial Officer, will continue in his role as Controller and Chief Accounting Officer. Grogan joins GE HealthCare from Xylem Inc., a leading global water solutions company with approximately $9 billion in revenue, where he has served as executive vice president and chief financial officer since 2023. At Xylem, he partnere

SCHEDULE 13G/A - GE HealthCare Technologies Inc. (0001932393) (Subject)

SCHEDULE 13G/A - GE HealthCare Technologies Inc. (0001932393) (Subject)

LOGIQ™ e Xi and LOGIQ™ e Si offer console-quality ultrasound in a compact laptop-sized system anywhere care can be deliveredii GE HealthCare today announced the introduction of the LOGIQ™ e family, featuring LOGIQ™ e Xi and LOGIQ™ e Si, two compact laptop ultrasound systems designed to help clinicians deliver simple, fast, and confident ultrasound imaging where it’s needed across care settings.ii Building on the legacy of LOGIQ e, the LOGIQ e family pairs a reliable console-level performance with a compact, intuitive design combining AI-powered featuresiii and workflow tools that support portability and flexibility for care beyond traditional imaging departments. "Healthcare delivery

Following the introduction of Invenia™ ABUS Prime at the Society of Breast Imaging Annual Symposium, the installation at BeSound in Los Angeles marks one of the first in the U.S., expanding access to supplemental screening for women with dense breasts ABUS StreamVue™* is a zero-footprint, browser-based reading solution designed to enable remote exam review from virtually anywhere across enterprise imaging networks and high-volume breast centers GE HealthCare today announced the launch of Invenia™ ABUS (Automated Breast Ultrasound) Prime and ABUS StreamVue™, a redesigned enterprise viewer that recently received U.S. Food and Drug Administration (FDA) 510(k) clearance and CE Marking, e

8-K - GE HealthCare Technologies Inc. (0001932393) (Filer)

10-Q - GE HealthCare Technologies Inc. (0001932393) (Filer)

8-K - GE HealthCare Technologies Inc. (0001932393) (Filer)

Revenue growth of 5.7%, and Organic revenue growth* of 3.5% Record organic orders growth of 11.1%, book-to-bill of 1.15 times and backlog of $23.9 billion Net income margin of 10.6% and Adjusted earnings before interest and taxes (EBIT) margin* of 14.2%; diluted earnings per share (EPS) of $1.24 grew 16.5% and Adjusted EPS* of $1.13 grew 6.6% Cash flow from operating activities of $168 million and Free cash flow* of $68 million Reaffirms full-year 2026 guidance GE HealthCare (NASDAQ:GEHC) today reported financial results for the second quarter ended June 30, 2026. GE HealthCare President and CEO Peter Arduini said, "We delivered record orders and backlog in the second quar

8-K - GE HealthCare Technologies Inc. (0001932393) (Filer)

James (Jay) Saccaro to step down as Chief Financial Officer (CFO) of GE HealthCare Preliminary second quarter results reflect business momentum: On a year-over-year basis, Revenue growth of 5.7% and Organic revenue growth* of 3.5%; Adjusted earnings per share (EPS)* performance ahead of prior expectation Reaffirms full-year 2026 guidance GE HealthCare (NASDAQ:GEHC) today announced that Jay Saccaro will step down as Vice President and Chief Financial Officer for an expanded role outside of the medical technology industry. The Company has appointed George Newcomb, currently Controller and Chief Accounting Officer, as interim Chief Financial Officer. Mr. Saccaro will remain with the

MIM Anyware is designed to deliver secure, healthcare system-controlled access to the full portfolio of GE HealthCare’s MIM software solutions through a web browser, regardless of their location. The platform enables simultaneous clinical review and processing of imaging data across departments to enhance clinical collaboration and patient care delivery. GE HealthCare (NASDAQ:GEHC) today announced the introduction of MIM Anyware™, a remote access platform that provides secure, healthcare system-controlled access to imaging data through a web browser without requiring local software installation. By enabling authorized users to access MIM software applications from virtually any locat

More than 1,300 pieces of technology to be added across Catholic Health hospitals and ambulatory locations, expanding access to advanced imaging, diagnostics and specialized care closer to home AI-powered technologies to support scheduling, operations, diagnostics, and monitoring across on-device, departmental and enterprise-level applications 10-year Care Alliance combines technology modernization with service support designed to help improve equipment reliability, operational efficiencies and care consistency across Catholic Health Catholic Health, an integrated health system located on Long Island, NY, and GE HealthCare (NASDAQ:GEHC) announced today a 10-year strategic partners

BMO Capital Markets initiated coverage of GE HealthCare with a rating of Market Perform and set a new price target of $70.00

A novel theranostics study explores imaging- and data-informed approaches to support individualized treatment decisions and expand access to theranostics Collaboration stems from a 2023 Strategic Radiology Research Alliance between Mayo Clinic and GE HealthCare, aimed at transforming the experience of patients and clinicians in the practice of radiology and the delivery of novel therapies GE HealthCare and Mayo Clinic today announced the MI-BET (Molecular Imaging Biomarker-Based End of Therapy Trial) research collaboration, a novel theranostics study designed to explore a more personalized approach to radioligand therapy (RLT) for patients with advanced prostate cancer. This collabor

GE HealthCare (NASDAQ:GEHC) will announce its second quarter 2026 financial results before the market opens on Wednesday, July 29, 2026. The GE HealthCare management team will also host a conference call and webcast at 8:30 a.m. Eastern Time / 7:30 a.m. Central Time on that same day, which will be a live webcast and accessible at https://investor.gehealthcare.com/news-events/events. The earnings release, accompanying financial information, and webcast replay also will be posted at the same link on the GE HealthCare Investor Relations website. About GE HealthCare Technologies Inc. GE HealthCare is a leading global healthcare solutions provider of advanced medical technology, pharmaceutic

The Board of Directors of GE HealthCare Technologies Inc. (NASDAQ:GEHC) today declared a cash dividend of $0.035 per share of Common Stock for the second quarter of 2026 payable on August 14, 2026, to all shareholders of record as of July 24, 2026.About GE HealthCare Technologies Inc.GE HealthCare is a leading global healthcare solutions provider of advanced medical technology, pharmaceutical diagnostics, and AI, cloud and software solutions that help clinicians tackle the world’s most complex diseases. Serving patients and providers for 130 years, GE HealthCare is delivering bold innovations designed for the next era of medicine across its Advanced Imaging Solutions, Patient Care Solutions,

Upgrade capabilities are designed to help health systems harness the latest Allia™ innovations while maximizing existing infrastructure investments GE HealthCare today announced Allia™ platform upgrade pathways designed to help customers modernize select legacy Innova™ and Discovery™ Image Guiding Solutions (IGS) systems. These pathways provide access to Allia technologies and workflows that support efficiency and procedural decision-making while helping preserve existing infrastructure, avoid major construction work, extend interventional room lifetime, and minimize disruption to clinical operations. As procedural complexity and patient volumes grow and installed systems age, healthc

RBC Capital Mkts initiated coverage of GE HealthCare with a rating of Outperform and set a new price target of $80.00

GE HealthCare to showcase cloud-enabled solutions including Genesis Radiology Workspace and InteleShare at SIIM 2026 Enterprise imaging solutions are designed to help improve workflow and productivity, enabling better patient care GE HealthCare will showcase its latest enterprise imaging solutions at the Society for Imaging Informatics in Medicine (SIIM) 2026 Annual Meeting in Pittsburgh, PA. Medical imaging departments today are under immense pressure from all sides including rising imaging volumes and increasing case complexity, while staffing shortages continue to grow. According to the American College of Radiology (ACR), radiologist workforce shortages have been identified as

Marking the evolution of MIM AI-enabled auto-contouring software, MIM Contour ProtégéAI+ 2.0 introduces new models, including a Magnetic Resonance (MR) Brain model, as well as an updated Computed Tomography (CT) Male Pelvis model, expanding clinical capabilities across key anatomical regions. GE HealthCare will showcase MIM Contour ProtégéAI+ 2.0 at booth #202 during the American Association of Medical Dosimetrists 51st Annual Meeting taking place June 7-10, 2026 in Orlando, Florida. GE HealthCare (NASDAQ:GEHC) today announced it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for MIM Contour ProtégéAI+™ 2.0, an AI-enabled auto-contouring softw

SD - GE HealthCare Technologies Inc. (0001932393) (Filer)

4 - GE HealthCare Technologies Inc. (0001932393) (Issuer)